Value-Based Agreements in Rare Disease: Focus on Hereditary Amyloid Transthyretin Amyloidosis

Supplements and Featured PublicationsValue-Based Agreements in Rare Disease: Focus on Hereditary Amyloid Transthyretin Amyloidosis

The American Journal of Managed Care® hosted a scientific interchange titled “Value-Based Agreements in Rare Disease” on September 30, 2020. This publication highlights key discussion points and insights from this event.

© 2023 MJH Life Sciences
AJMC®
All rights reserved.